| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 200,778 | 187,676 | 192,609 | 232,568 | | Cost of Revenue | 109,080 | 105,940 | 106,800 | 121,679 | | | Gross Profit | 91,698 | 81,736 | 85,809 | 110,889 | | | Operating Expenses | | Research Development | 21,155 | 20,614 | 21,804 | 20,653 | | Selling General and Administrative | 49,141 | 42,810 | 44,901 | 52,523 | | Non Recurring | 3,603 | 3,353 | 2,296 | 165,391 | | Others | 2,649 | 2,574 | 2,634 | 4,671 | | | | Total Operating Expenses | 76,548 | 69,351 | 71,635 | 243,238 | | | | Operating Income or Loss | 15,150 | 12,385 | 14,174 | (132,349) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,190 | 864 | (423) | 3,658 | | Earnings Before Interest And Taxes | 16,340 | 13,249 | 13,751 | (128,691) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 16,340 | 13,249 | 13,751 | (128,691) | | Income Tax Expense | 5,229 | 4,238 | 4,399 | (11,330) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,111 | 9,011 | 9,352 | (117,361) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,111 | 9,011 | 9,352 | (117,361) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,111 | $9,011 | $9,352 | ($117,361) |
|
1.52% Nasdaq 
Income Statement
